Cargando…

Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis

BACKGROUND: Cancer-associated fibroblasts (CAFs) play a pivotal role in cancer progression and are known to mediate endocrine and chemotherapy resistance through paracrine signaling. Additionally, they directly influence the expression and growth dependence of ER in Luminal breast cancer (LBC). This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, An, Xu, Xiang-Nan, Luo, Zhou, Huang, Xiao, Gong, Rong-Quan, Fu, De-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191114/ https://www.ncbi.nlm.nih.gov/pubmed/37207166 http://dx.doi.org/10.3389/fonc.2023.1191660

Ejemplares similares

SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer
por: Gong, Yajie, et al.
Publicado: (2020)

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity
por: Chen, Fei, et al.
Publicado: (2022)

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer
por: Yang, Ganglong, et al.
Publicado: (2023)

Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2021)

Identification of Luminal A breast cancer by using deep learning analysis based on multi-modal images
por: Liu, Menghan, et al.
Publicado: (2023)

Identification of a centrosome-related prognostic signature for breast cancer
por: Fang, Zhou, et al.
Publicado: (2023)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
por: Xiao, Bin, et al.
Publicado: (2018)

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis
por: Martínez-Aranda, Antonio, et al.
Publicado: (2017)

Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype
por: Wang, Yunmei, et al.
Publicado: (2020)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Should a Multigene Signature be Used in all Luminal Early Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2019)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
por: Diana, Anna, et al.
Publicado: (2022)

Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts
por: Jones, Kelvin M., et al.
Publicado: (2018)

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
por: Zhang, Lianmei, et al.
Publicado: (2023)

RNA m(6)A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer
por: Yang, Lin, et al.
Publicado: (2021)

Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer
por: Kim, Hee Jeong, et al.
Publicado: (2010)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
por: Metovic, Jasna, et al.
Publicado: (2022)

Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
por: Yang, Yan, et al.
Publicado: (2021)

The role of cancer-associated fibroblasts in breast cancer metastasis
por: Li, Yi, et al.
Publicado: (2023)

Risk Signature of Cancer-Associated Fibroblast–Secreted Cytokines Associates With Clinical Outcomes of Breast Cancer
por: Sun, Chunxiao, et al.
Publicado: (2021)

Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021)

Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation
por: Kang, Seo Young, et al.
Publicado: (2021)

A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer
por: Zhong, Yue, et al.
Publicado: (2022)

Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes
por: Koufaris, Costas, et al.
Publicado: (2021)

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer
por: Wang, Long, et al.
Publicado: (2021)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer
por: Liu, Junhao, et al.
Publicado: (2021)

Identification of Flap Endonuclease 1 With Diagnostic and Prognostic Value in Breast Cancer
por: Wu, Min, et al.
Publicado: (2021)

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer
por: Li, Zan, et al.
Publicado: (2022)

Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients
por: Tong, Yiwei, et al.
Publicado: (2022)

Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h7t9v4f21acp1ov9h4m1gt2kkk